Oracle Launches AI Data Platform for Life Sciences Research
Oracle announced in a press release the launch of its Oracle Life Sciences AI Data Platform, a generative AI-driven analytics solution aimed at accelerating research and development, clinical trials, and commercialization for pharmaceutical, medical device, and life sciences organizations.
The platform combines proprietary and third-party data with more than 129 million de-identified longitudinal records from Oracle Health Real-World Data. It uses generative AI and agentic reasoning to interpret information and deliver actionable insights within research and clinical workflows.
Organizations can use built-in AI agents or create their own to perform tasks such as identifying label expansion opportunities, conducting Health Economics and Outcomes Research, generating synthetic control arms, and monitoring safety data. The system also allows researchers to ask open-ended questions, refine hypotheses, and track data lineage.
The platform integrates with Oracle Cloud Infrastructure, Oracle Life Sciences AI Application Suite, Oracle Fusion Cloud SCM, Oracle Fusion Cloud Sales, and Oracle Health AI Application Suite, providing a unified environment for life sciences operations. Oracle Corporation will showcase the platform at the SCOPE conference in Orlando, Florida, from February 2–5, 2026.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Oct 17 Masimo Gets FDA Clearance for AFib Detection on Radius VSM Oct 16 Study Tests Smartphone AI for Children's Lung Sounds Oct 16 Manhattan Physician Invests in RunPractice Oct 16 Attilio appoints Buck Institute CEO Eric Verdin as cochairman Oct 16 Aignostics launches HETA Clinical for pathology workflowsLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Whitepaper
Tensordyne Napier: What If One Rack Could Do the Work of Nine?
Tensordyne
This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.
Read moreYou may also like
MyOme Expands Genomic Risk Platform Worldwide on Oracle Cloud
Oracle and Buck Institute Use Health Data for Aging Research
Illumina Launches BioInsight Platform for Genomic Research
Manulife Launches Enterprise AI Platform
Domino Data Lab and EPAM Partner on Validated AI for Life Sciences
Daily AI Brief: the AI news that matters, in your inbox.